This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- In the third video of a series on the approval of aducanumab for Alzheimer disease, Pamela Spicer, MS, senior analyst at Datamonitor with Informa Pharma Intelligence, discussed the data supporting its approval and where some of the controversies originate.
- An article that discusses the challenges involved with the price of specialty medications and how pharmacy benefit managers can help manage the high costs associated with these treatments.
- A pharmacy quiz on treatments for heart failure.